Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?
Interactive Video
•
Social Studies, Health Sciences, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The transcript discusses the progress of COVID-19 vaccines by Moderna and Pfizer, highlighting Moderna's 94% effectiveness in trials and the use of mRNA technology. Both vaccines are seeking emergency use authorization from the FDA, with hearings scheduled in December. Initial vaccine doses will be limited, with widespread availability expected by mid-next year. Public health measures remain crucial until vaccines are widely distributed. A CDC board will decide on vaccine prioritization.
Read more
1 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What new insight or understanding did you gain from this video?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
